Skip to content

Tango Therapeutics TNGX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

CG Oncology logo
CG OncologyCGON
$4.58M+342%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$40.77M+0.5%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$85.36M+49.8%
Roivant Sciences logo
Roivant SciencesROIV
$107.44M+7.3%
Guardant Health logo
Guardant HealthGH
$201.09M+5.8%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$50.8M

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.55B+1,915%

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Tango Therapeutics’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's operating lease liabilities (total)?
Tango Therapeutics (TNGX) reported operating lease liabilities (total) of $33.57M in Q4 2025.
What is the long-term trend for Tango Therapeutics's operating lease liabilities (total)?
Over 3 years (2021 to 2025), Tango Therapeutics's operating lease liabilities (total) has grown at a 181.6% compound annual growth rate (CAGR), from $1.5M to $33.57M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.